Recent Quotes

My Watchlist

Indicators

Mineralys Therapeutics, Inc. - Common Stock (NQ: MLYS )

13.98 -0.18 (-1.24%)

Streaming Delayed Price Updated: 11:32 AM EST, Nov 8, 2024 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	69,227
Open	14.30
Bid (Size)	13.94 (7)
Ask (Size)	14.03 (4)
Prev. Close	14.16
Today's Range	13.79 - 14.61
52wk Range	5.850 - 16.91
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Insights into Mineralys Therapeutics's Upcoming Earnings

Today 10:02 EST

Via Benzinga

MLYS INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Mineralys Therapeutics, Inc. and Encourages Investors to Contact the Firm!

September 20, 2024

From Bronstein, Gewirtz & Grossman, LLC

Via Business Wire

Performance

YTD	+61.12%	+61.12%
1 Month	+2.83%	+2.83%
3 Month	+25.20%	+25.20%
6 Month	-2.00%	-2.00%
1 Year	+71.38%	+71.38%

More News

MLYS INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Mineralys Therapeutics, Inc. and Encourages Investors to Contact the Firm!

September 12, 2024

From Bronstein, Gewirtz & Grossman, LLC

Via Business Wire

Mineralys Therapeutics Earnings Preview

March 20, 2024

Via Benzinga

Where Mineralys Therapeutics Stands With Analysts

May 16, 2023

Via Benzinga

Where Mineralys Therapeutics Stands With Analysts

March 16, 2023

Via Benzinga

MLYS Investors Have Opportunity to Join Mineralys Therapeutics, Inc. Fraud Investigation with the Schall Law Firm

September 09, 2024

From Schall Law

Via GlobeNewswire

MLYS Stock Earnings: Mineralys Therapeutics Misses EPS for Q2 2024

August 13, 2024

Via InvestorPlace

MLYS Stock Earnings: Mineralys Therapeutics Misses EPS for Q1 2024

May 09, 2024

Via InvestorPlace

MLYS Stock Earnings: Mineralys Therapeutics Beats EPS for Q4 2023

March 21, 2024

Via InvestorPlace

Arm Holdings Posts Upbeat Results, Joins Hershey, CyberArk Software, Wynn Resorts And Other Big Stocks Moving Higher On Thursday

February 08, 2024

Via Benzinga

Earnings Scheduled For March 21, 2024

March 21, 2024

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session

February 08, 2024

Via Benzinga

Why Compass Minerals International Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

February 08, 2024

Via Benzinga

Praxis Bioresearch Expands its Board of Directors with Appointment of Adam Levy

September 19, 2023

From Praxis Bioresearch, Inc.

Via GlobeNewswire

Why AAR Shares Are Trading Lower By 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session

December 22, 2023

Via Benzinga

$5M Bet On TreeHouse Foods? Check Out These 3 Stocks Insiders Are Buying

September 11, 2023

Via Benzinga

The Acute Hospital Care Market Is Worth Over $3 Trillion, And Windtree Therapeutics Brings A First-In-Class Drug To An Active Segment Of This Market

July 17, 2023

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday

March 21, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For March 7, 2023

March 07, 2023

Via Benzinga

Earnings Scheduled For March 15, 2023

March 15, 2023

Via Benzinga

Around $11M Bet On Insight Enterprises? Check Out These 4 Stocks Insiders Are Buying

February 17, 2023

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday

February 14, 2023

Via Benzinga

Stocks That Hit 52-Week Lows On Monday

February 13, 2023

Via Benzinga

There's a Lot to Love About Mineralys' Valentine's Day IPO

February 13, 2023

Via MarketBeat

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.